+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

India Disposable Syringes Market by Product Type, Application, and End User: Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5521483
  • Report
  • October 2021
  • Region: India
  • 112 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Albert David
  • Becton
  • Dickinson India Pvt. ltd.
The India disposable syringes market was valued at $148.00 million in 2020, and is projected to reach $385.54 million by 2030, registering a CAGR of 10.3% from 2021 to 2030.



Disposable syringes are medical devices employed for one-time administration of therapeutic agents into the body of a patient. Furthermore, these devices are also used in the extraction of blood samples from patients, which are then analyzed to diagnose a medical condition. In addition, disposable syringes are also employed in administration of weakened strains of viruses to build immunity against them. Moreover, syringes draw out blood and administer drugs with the help of a piston mechanism. There are different types of syringes present in the market, which offer different advantages.

The major factor that contributes to the growth of the India disposable syringes market includes surge in use of injectable drugs, favorable government policy and regulation regarding disposable syringes. Furthermore, other factors such as rise in healthcare expenditure, increase in prevalence of various chronic diseases that require use of disposable syringe systems, and surge in cases of needlestick injuries also fuel the growth of the market. However, increased cost of disposable syringes restricts the market growth. Conversely, high growth potential for use of disposable syringes in India and technological advancements of product is expected to offer lucrative opportunities during the forecast period.

The India disposable syringes market size is studied on the basis of product type, application, and end user to provide a detailed assessment of the market. On the basis of product type, it is divided into conventional disposable syringes and safety disposable syringes. By application, it is bifurcated into immunization injections and therapeutic injections. By end user, it is classified into hospital, diagnostic laboratories, blood banks, pharmaceutical industry, veterinary purposes, and others.

Major key players operating in the market include Albert David, Baxter International India Pvt ltd, B. Braun Medical India Pvt ltd, Becton, Dickinson India Pvt ltd, Cardinal Health India Pvt ltd, Hindustan Syringe and Medical Co. Ltd, Nipro Medical Corporation India Pvt ltd, Novo Nordisk India Pvt ltd, Terumo Corporation India Pvt ltd and Teleflex Medical Pvt Ltd.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS


By Product Type

  • Conventional disposable syringe
  • Safety disposable syringe

By Application

  • Immunization injections
  • Therapeutic injections

By End User

  • Hospital
  • Diagnostic Laboratories
  • Blood Banks
  • Pharmaceutical industry
  • Veterinary purposes
  • Others

KEY MARKET PLAYERS

  • Albert David Ltd
  • Baxter International India Pvt Ltd
  • B. Braun Medical India Pvt Ltd
  • Becton, Dickinson India Pvt Ltd
  • Cardinal Health India Pvt ltd
  • Hindustan Syringe and Medical. Ltd
  • Nipro Medical Corporation India Pvt Ltd
  • Novo Nordisk India Pvt Ltd
  • Terumo Corporation India Pvt Ltd
  • Teleflex Medical Pvt Ltd.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Gerresheimer AG
  • Smiths Medical
  • Thomas Scientific
Frequently Asked Questions about the India Disposable Syringes Market

What is the estimated value of the India Disposable Syringes Market?

The India Disposable Syringes Market was estimated to be valued at $148.0 million in 2020.

What is the growth rate of the India Disposable Syringes Market?

The growth rate of the India Disposable Syringes Market is 10.0%, with an estimated value of $385.5 million by 2030.

What is the forecasted size of the India Disposable Syringes Market?

The India Disposable Syringes Market is estimated to be worth $385.5 million by 2030.

Who are the key companies in the India Disposable Syringes Market?

Key companies in the India Disposable Syringes Market include Albert David, Baxter International India Pvt. ltd., B. Braun Medical India Pvt. ltd., Becton, Dickinson India Pvt. ltd., Cardinal Health India Pvt. ltd., Hindustan Syringe and Medical Co. Ltd, Nipro Medical Corporation India Pvt. ltd. and Terumo Corporation India Pvt. Ltd..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Albert David
  • Becton
  • Dickinson India Pvt. ltd.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Key forces shaping disposable syringes industry/market
3.4. Market dynamics
3.4.1.1. Rise in prevalence of needlestick injuries
3.4.1.2. Surge in healthcare expenditure
3.4.1.3. Favorable government initiatives
3.4.1.4. Increase in prevalence of chronic conditions and infectious diseases
3.4.2. Restraints
3.4.2.1. High cost of disposable syringes
3.4.2.2. Availability of alternative modes of delivery
3.4.3. Opportunity
3.4.3.1. High growth potential in India
3.4.4. Impact Analysis
3.5. Impact of Covid-19 on the market

CHAPTER 4: INDIA DISPOSABLE SYRINGES MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Conventional Disposable Syringes
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Safety Disposable Syringes
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

CHAPTER 5: INDIA DISPOSABLE SYRINGES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Immunization Injections
5.2.1. Market size and forecast
5.3. Therapeutic Injections
5.3.1. Market size and forecast

CHAPTER 6: INDIA DISPOSABLE SYRINGES MARKET, BY END USER
6.1.1. Market size and forecast
6.2. Hospital
6.2.1. Market size and forecast
6.3. Diagnostic Laboratories
6.3.1. Market size and forecast
6.4. Blood banks
6.4.1. Market size and forecast
6.5. Pharmaceutical industries
6.5.1. Market size and forecast
6.6. Veterinary purposes
6.6.1. Market size and forecast
6.7. Others
6.7.1. Market size and forecast

CHAPTER 7: COMPANY PROFILES
7.1. Albert David Ltd
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. BAXTER INTERNATIONAL.INDIA PVT LTD
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.3. B. BRAUN MEDICAL INDIA PVT LTD
7.3.1.1.1.1. Company overview
7.3.2.1.1.2. Company snapshot
7.3.3. Operating business segments
7.3.4.1.1.4. Product portfolio
7.3.5.1.1.5. Business performance
7.4. BECTON DICKINSON & COMPANY INDIA PVT LTD
7.4.1. Company overview
7.4.2. Company Snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. CARDINAL HEALTH INDIA PVT LTD.
7.5.1. Company overview
7.5.2. Company Snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. HINDUSTAN SYRINGES AND MEDICAL DEVICES LTD
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.1. Key strategic moves and developments
7.7. NIPRO MEDICAL CORPORATION INDIA PVT LTD
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. NOVO NORDISk INDIA PVT LTD
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. TERUMO CORPORATION INDIA PVT LTD
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. TELEFLEX MEDICAL PVT LTD
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance

List of Tables
TABLE 01. INDIA DISPOSABLE SYRINGES MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. INDIA DISPOSABLE SYRINGES MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 03. INDIA DISPOSABLE SYRINGES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 04. ALBERT: COMPANY SNAPSHOT
TABLE 05. ALBERT: BUSINESS SEGMENT
TABLE 06. BAXTER: COMPANY SNAPSHOT
TABLE 07. BAXTER: BUSINESS SEGMENT
TABLE 08. B.BRAUN: COMPANY SNAPSHOT
TABLE 09. B BRAUN: OPERATING SEGMENTS
TABLE 10. B. BRAUN: PRODUCT PORTFOLIO
TABLE 11. BD: COMPANY SNAPSHOT
TABLE 12. BD: OPERATING SEGMENTS
TABLE 13. BD: PRODUCT PORTFOLIO
TABLE 14. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 15. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 16. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 17. HMD: COMPANY SNAPSHOT
TABLE 18. HMD: OPERATING SEGMENTS
TABLE 19. HMD: PRODUCT PORTFOLIO:
TABLE 20. NIPRO: COMPANY SNAPSHOT
TABLE 21. NIPRO: OPERATING SEGMENTS
TABLE 22. NIPRO: PRODUCT PORTFOLIO:
TABLE 23. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 24. NOVO NORDISK: OPERATING SEGMENTS
TABLE 25. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 26. TERUMO: COMPANY SNAPSHOT
TABLE 27. TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 28. TERUMO: PRODUCT PORTFOLIO
TABLE 29. TELEFLEX: COMPANY SNAPSHOT
TABLE 30. TELEFLEX: PRODUCT SEGMENTS
TABLE 31. TELEFLEX: PRODUCT PORTFOLIO

List of Figures
FIGURE 01. INDIA DISPOSABLE SYRINGES MARKET SEGMENTATION
FIGURE 02. TOP PLAYER POSITIONING, 2020
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. HIGH INTENSITY OF RIVALRY
FIGURE 08. HIGH THREAT OF NEW ENTRANT
FIGURE 09. IMPACT ANALYSES, INDIA DISPOSABLE SYRINGES MARKET
FIGURE 10. INDIA DISPOSABLE SYRINGES MARKET, BY SAFETY DISPOSABLE SYRINGES 2020-2030 ($MILLION)
FIGURE 11. INDIA DISPOSABLE SYRINGES MARKET, BY SAFETY DISPOSABLE SYRINGES 2020-2030 ($MILLION)
FIGURE 12. INDIA DISPOSABLE SYRINGES MARKET, BY IMMUNIZATION INJECTIONS 2020-2030 ($MILLION)
FIGURE 13. INDIA DISPOSABLE SYRINGES MARKET, BY THERAPEUTIC INJECTIONS 2020-2030 ($MILLION)
FIGURE 14. INDIA DISPOSABLE SYRINGES MARKET, BY HOSPITAL 2020-2030 ($MILLION)
FIGURE 15. INDIA DISPOSABLE SYRINGES MARKET, BY DIAGNOSTIC LABORATORIES 2020-2030 ($MILLION)
FIGURE 16. INDIA DISPOSABLE SYRINGES MARKET, BY BLOOD BANKS 2020-2030 ($MILLION)
FIGURE 17. INDIA DISPOSABLE SYRINGES MARKET, BY PHARMACEUTICAL INDUSTRY 2020-2030 ($MILLION)
FIGURE 18. INDIA DISPOSABLE SYRINGES MARKET, BY VETERNARY PURPOSES 2020-2030 ($MILLION)
FIGURE 19. INDIA DISPOSABLE SYRINGES MARKET, BY OTHERS 2020-2030 ($MILLION)
FIGURE 20. NET SALES, 2018-2020 ($MILLION)
FIGURE 21. ALBERT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 22. NET SALES, 2018-2020 ($MILLION)
FIGURE 23. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2020 (%)
FIGURE 24. BAXTER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 25. B. BRAUN: REVENUE, 2018-2020 ($MILLION)
FIGURE 26. B. BRAUN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 28. BD: REVENUE, 2018-2020 ($MILLION)
FIGURE 29. BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30. BD: REVENUE SHARE BY REGION, 2020
FIGURE 31. CARDINAL HEALTH: REVENUE, 2018-2020 ($MILLION)
FIGURE 32. CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. CARDINAL HEALTH: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34. NIPRO: NET SALES, 2018-2020 ($MILLION)
FIGURE 35. NIPRO: REVENUE SHARE BY SEGMENTS, 2020 (%)
FIGURE 36. NIPRO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37. NET SALES, 2018-2020 ($MILLION)
FIGURE 38. NOVO NORDISK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39. NOVO NORDISK: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 40. TERUMO: NET SALES, 2017-2019 ($MILLION)
FIGURE 41. TERUMO: REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 42. TERUMO: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 43. TELEFLEX: NET SALES, 2018-2020 ($MILLION)
FIGURE 44. TELEFLEX: REVENUE SHARE BY SEGMENTS, 2020 (%)
FIGURE 45. TELEFLEX: REVENUE SHARE BY REGION, 2020 (%)
Note: Product cover images may vary from those shown
  • Albert David
  • Baxter International India Pvt. ltd.
  • B. Braun Medical India Pvt. ltd.
  • Becton
  • Dickinson India Pvt. ltd.
  • Cardinal Health India Pvt. ltd.
  • Hindustan Syringe and Medical Co. Ltd
  • Nipro Medical Corporation India Pvt. ltd.
  • Novo Nordisk India Pvt. ltd.
  • Terumo Corporation India Pvt. Ltd.
  • Teleflex Medical Pvt. ltd.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...